BrainStorm Cell Therapeutics Announces the Presentation of New Analyses from the Phase 3 Trial of NurOwn in ALS at the 4th Annual ALS ONE Research…

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc.(NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the presentation of new analyses from the Phase 3 trial of NurOwn at the 4th Annual ALS ONE Research Symposium

Read more
‘Sleeping’ cancer cells explain why childhood leukaemia returns after years of treatment – The Institute of Cancer Research, London – The Institute of…

Image: deformed cells in the bone marrow, typical of leukaemia Leukaemic cancer cells can go to sleep and thus avoid the effects of chemotherapy, sometimes for years. It turns out that whether the cell is in this dormant state or not increases its chances of surviving chemotherapy and is completely independent from its mutations, as previously assumed. The discovery, made by a collaboration between researchers at The Institute of Cancer Research, London, and University College London (UCL),could help direct research towards new, more effective treatments for childhood leukaemia that stop cancer from coming back.

Read more
InGeneron Publishes Significant Support for the Existence of Naturally Pluripotent Stem Cells in All Organs in the Adult Body – StreetInsider.com

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. 20 years of research finds evidence of vascular-associated, naturally pluripotent stem cells in the adult body (vaPS cells) with encouraging potential for regenerative medicine HOUSTON--(BUSINESS WIRE)--InGeneron, Inc., a clinical stage regenerative medicine and cell therapy company, announced the publication of the first comprehensive analysis providing significant support for the existence of naturally pluripotent stem cells in all organs

Read more